Oh Won-il
other
About
Oh Won-il, rendered by MEDIPOST in English as Wonil Oh, is the CEO and President of South Korean biotechnology company MEDIPOST. The company focuses on stem-cell therapeutics and regenerative medicine, including CARTISTEM for knee osteoarthritis. Public records also show him as a named inventor on MEDIPOST patent filings.
Areas of interest
biotechstem cell therapeuticsregenerative medicineosteoarthritiscell therapy commercializationglobal clinical development